<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39339502</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Development of a Simple and Validated LC-MS/MS Method for Quantitative Determination of Ketotifen in Beagle Dog Plasma and Its Application to Bioequivalence Study of Ketotifen Syrup Dosage Form.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4505</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules29184505</ELocationID><Abstract><AbstractText>A highly accurate, precise, and simple liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for ketotifen (KTF) estimation from Beagle dog plasma was developed and validated, with ketotifen-d3 (KTF-d3) as the internal standard (IS). KTF and IS were detected on an API 4000 mass spectrometer in multiple reaction monitoring (MRM) mode in electrospray ionization (ESI) positive ionization mode. The transitions were monitored at <i>m/z</i> 310.2 → 96.0 for KTF and <i>m/z</i> 313.2 → 99.1 for IS. KTF and IS were extracted from plasma using liquid-liquid extraction with methyl tertiary-butyl ether and then analyzed for 3 min with extracted samples (7 µL) into the LC-MS/MS system. Analytes were separated on a Luna<sup>®</sup> Hilic column (50 × 2.0 mm i.d., 3 μm) using the Nexera X2 HPLC. The mobile phase A consisted of 10 mmol/L ammonium formate (pH 3.0), while mobile phase B consisted of 0.05% formic acid in acetonitrile. The ratio of mobile phase was 5:95 (<i>v</i>/<i>v</i>) at a flow rate of 0.2 mL/min. The method has been thoroughly validated in accordance with the bioanalytical method validation guidelines established by the Ministry of Food and Drug Safety in Korea and the U.S. Food and Drug Administration, addressing selectivity, lower limit of quantification, linearity, carryover, precision, accuracy, recovery, matrix effect, and stability. The developed LC-MS/MS method was effectively utilized for the bioequivalence assessment of ketotifen in Beagle dog plasma following the oral administration of ketotifen syrup.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Eunseo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0000-5927-7168</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Science, Graduated School, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyung Hee Drug Analysis Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Wang-Seob</ForeName><Initials>WS</Initials><Identifier Source="ORCID">0000-0002-0903-1386</Identifier><AffiliationInfo><Affiliation>Kyung Hee Drug Analysis Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Doowon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Science, Graduated School, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyung Hee Drug Analysis Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yuna</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Science, Graduated School, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyung Hee Drug Analysis Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Hyeong Geun</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Daewon Pharm. Co., Ltd., 386 Cheonhodae-ro, Gwangjin-gu, Seoul 04808, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Soobok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Daewon Pharm. Co., Ltd., 386 Cheonhodae-ro, Gwangjin-gu, Seoul 04808, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regulatory Science, Graduated School, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Suk Han</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Daewon Pharm. Co., Ltd., 386 Cheonhodae-ro, Gwangjin-gu, Seoul 04808, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Fundamental Pharmaceutical Science, Graduated School, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yeo Jin</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0002-0635-4374</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung-Tae</ForeName><Initials>KT</Initials><Identifier Source="ORCID">0000-0002-3141-3727</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Science, Graduated School, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyung Hee Drug Analysis Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DW-5223</GrantID><Agency>Daewon Pharmaceutical Co., Ltd., Republic of Korea</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X49220T18G</RegistryNumber><NameOfSubstance UI="D007665">Ketotifen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="Y">Tandem Mass Spectrometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007665" MajorTopicYN="Y">Ketotifen</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013810" MajorTopicYN="Y">Therapeutic Equivalency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000097922" MajorTopicYN="N">Liquid Chromatography-Mass Spectrometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Beagle dog plasma</Keyword><Keyword MajorTopicYN="N">LC–MS/MS</Keyword><Keyword MajorTopicYN="N">bioanalytical method validation</Keyword><Keyword MajorTopicYN="N">bioequivalence</Keyword><Keyword MajorTopicYN="N">ketotifen</Keyword><Keyword MajorTopicYN="N">syrup</Keyword></KeywordList><CoiStatement>The authors declare that this study received funding from Daewon Pharmaceutical Co., Ltd. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339502</ArticleId><ArticleId IdType="pmc">PMC11433888</ArticleId><ArticleId IdType="doi">10.3390/molecules29184505</ArticleId><ArticleId IdType="pii">molecules29184505</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alali F.Q., Tashtoush B.M., Najib N.M. Determination of ketotifen in human plasma by LC-MS. J. Pharm. Biomed. Anal. 2004;34:87–94. doi: 10.1016/j.japna.2003.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japna.2003.08.001</ArticleId><ArticleId IdType="pubmed">14738922</ArticleId></ArticleIdList></Reference><Reference><Citation>Frag E.Y., Mohamed G.G., Khalil M.M., Hwehy M.M. Potentiometric determination of ketotifen fumarate in pharmaceutical preparations and urine using carbon paste and PVC membrane selective electrodes. Int. J. Anal. Chem. 2011;2011:604741. doi: 10.1155/2011/604741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/604741</ArticleId><ArticleId IdType="pmc">PMC3195277</ArticleId><ArticleId IdType="pubmed">22013443</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant S.M., Goa K.L., Fitton A., Sorkin E.M. Ketotifen: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs. 1990;40:412–448. doi: 10.2165/00003495-199040030-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-199040030-00006</ArticleId><ArticleId IdType="pubmed">2226222</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer H., Pfleger K. Identification and differentiation of alkylamine antihistamines and their metabolites in urine by computerized gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 1988;430:31–41. doi: 10.1016/S0378-4347(00)83131-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-4347(00)83131-X</ArticleId><ArticleId IdType="pubmed">2905706</ArticleId></ArticleIdList></Reference><Reference><Citation>Waheed N.A., Waheed S.A. Molecular Docking Study and Structure Based Design of Ketotifen and Some of its Analogues Including ADME and Toxicity Study. Int. J. Pharm. Res. 2020;12:1498.</Citation></Reference><Reference><Citation>Zhang L., Peng Y., Ren M., Li Y., Tang H. In vitro and in vivo Research of Sustained Release ketotifen fumarate for Treatment of asthma. J. Nanoparticle Res. 2022;24:94. doi: 10.1007/s11051-022-05475-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11051-022-05475-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhong D., Liu D., Wang Y., Han Y., Gu J. Determination of ketotifen and its conjugated metabolite in human plasma by liquid chromatography/tandem mass spectrometry: Application to a pharmacokinetic study. Rapid Commun. Mass Spectrom. 2003;17:2459–2463. doi: 10.1002/rcm.1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.1189</ArticleId><ArticleId IdType="pubmed">14608613</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bigot J.F., Begue J.M., Kiechel J.R., Guillouzo A. Species differences in metabolism of ketotifen in rat, rabbit and man: Demonstration of similar pathways in vivo and in cultured hepatocytes. Life Sci. 1987;40:883–890. doi: 10.1016/0024-3205(87)90037-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(87)90037-3</ArticleId><ArticleId IdType="pubmed">3821382</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam K.-D., Tak S.-K., Park J.-S., Cho M.-H., Yim S.-V., Shim W.-S., Cho H.-S., Park M.-S., Lee K.-T. Bioequivalence assessment of Fumatifen® tablet to Zaditen® tablet (ketotifen fumarate 1 mg) by liquid chromatography tandem mass spectrometry. J. Pharm. Investig. 2012;42:221–228. doi: 10.1007/s40005-012-0031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40005-012-0031-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi N., Taniuchi Y., Hamada K., Sudo J., Sekikawa H. Pharmacokinetics of ketotifen fumarate after intravenous, intranasal, oral and rectal administration in rabbits. Biol. Pharm. Bull. 2002;25:1614–1618. doi: 10.1248/bpb.25.1614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.25.1614</ArticleId><ArticleId IdType="pubmed">12499650</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahnen A., Lonnebo A., Beck O., Eckernas S.A., Dahlstrom B., Lindstrom B. Pharmacokinetics of ketotifen after oral administration to healthy male subjects. Biopharm. Drug Dispos. 1992;13:255–262. doi: 10.1002/bdd.2510130404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bdd.2510130404</ArticleId><ArticleId IdType="pubmed">1600111</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien-Larose C., Guerret M., Lavene D., Kiechel J. Quantification of ketotifen and its metabolites in human plasma by gas chromatography mass spectrometry. Biomed. Mass Spectrom. 1983;10:136–142. doi: 10.1002/bms.1200100307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bms.1200100307</ArticleId><ArticleId IdType="pubmed">6850066</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson S.K., Vaughn M.B., Jessen S.M., Lawal Y., Gresk C.J., Yan B., Maziasz T.J., Cook C.S., Karim A. Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption. J. Pharmacol. Exp. Ther. 2001;297:638–645.</Citation><ArticleIdList><ArticleId IdType="pubmed">11303053</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzvetanov S., Vatsova M., Drenska A., Gorantcheva J., Tyutyulkova N. Gas chromatographic-mass spectrometric method for quantitative determination of ketotifen in human plasma after enzyme hydrolysis of conjugated ketotifen. J. Chromatogr. B Biomed. Sci. Appl. 1999;732:251–256. doi: 10.1016/S0378-4347(99)00289-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-4347(99)00289-3</ArticleId><ArticleId IdType="pubmed">10517244</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsayed M.M. Development and validation of a rapid HPLC method for the determination of ketotifen in pharmaceuticals. Drug Dev. Ind. Pharm. 2006;32:457–461. doi: 10.1080/03639040500529135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03639040500529135</ArticleId><ArticleId IdType="pubmed">16638684</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui K., Takeuchi S., Haruna Y., Yamane M., Shimizu T., Hatsuma Y., Shimono N., Sunada M., Hayakawa M., Nishida T. Transverse comparison of mannitol content in marketed drug products: Implication for no-effect dose of sugar alcohols on oral drug absorption. J. Drug Deliv. Sci. Technol. 2020;57:101728. doi: 10.1016/j.jddst.2020.101728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jddst.2020.101728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane M., Matsui K., Sugihara M., Tokunaga Y. The provisional no-effect threshold of sugar alcohols on oral drug absorption estimated by physiologically based biopharmaceutics model. J. Pharm. Sci. 2021;110:467–477. doi: 10.1016/j.xphs.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2020.05.013</ArticleId><ArticleId IdType="pubmed">32470348</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert A.J. Hydrophilic-Interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. A. 1990;499:177–196. doi: 10.1016/S0021-9673(00)96972-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9673(00)96972-3</ArticleId><ArticleId IdType="pubmed">2324207</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauve B., Guillarme D., Cleon P., Veuthey J.L. Evaluation of various HILIC materials for the fast separation of polar compounds. J. Sep. Sci. 2010;33:752–764. doi: 10.1002/jssc.200900749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jssc.200900749</ArticleId><ArticleId IdType="pubmed">20183827</ArticleId></ArticleIdList></Reference><Reference><Citation>Henion J., Brewer E., Rule G. Peer reviewed: Sample preparation for LC/MS/MS: Analyzing biological and environmental samples. Anal. Chem. 1998;70:650A–656A. doi: 10.1021/ac981991q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac981991q</ArticleId><ArticleId IdType="pubmed">9784742</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drug Administration  Bioanalytical Method Validation Guidance for Industry. US Department of Health and Human Services.  [(accessed on 6 December 2021)];2018  Available online:  https://www.fda.gov/media/70858/download.</Citation></Reference><Reference><Citation>Ministry of Food and Drug Safety  Guideline on Bioanalytical Method Validation. 2013.  [(accessed on 6 December 2021)].  Available online:  https://www.mfds.go.kr/brd/m210/down.do?brd_id=data0010&amp;seq=13054data_tp=A&amp;file_seq=1.</Citation></Reference><Reference><Citation>de Boer T., Wieling J. Incurred sample accuracy assessment: Design of experiments based on standard addition. Bioanalysis. 2011;3:983–992. doi: 10.4155/bio.11.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio.11.36</ArticleId><ArticleId IdType="pubmed">21545346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs-General Considerations  U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)  [(accessed on 10 May 2023)];2014  Available online:  https://www.fda.gov/media/88254/download.</Citation></Reference><Reference><Citation>El-Kommos M.E., El-Gizawy S.M., Atia N.N., Hosny N.M. Analysis for commonly prescribed non-sedating antihistamines. Anal. Chem. Res. 2015;3:1–12. doi: 10.1016/j.ancr.2014.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ancr.2014.11.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankar P.R., Geethika A.S., Rachana G., Babu P.S., Bhargavi J. Bioanalytical method validation: A comprehensive review. Int. J. Pharm. Sci. Rev. Res. 2019;9:50–58.</Citation></Reference><Reference><Citation>Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L. Bioanalytical method validation—A revisit with a decade of progress. Pharm. Res. 2000;17:1551–1557. doi: 10.1023/A:1007669411738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1007669411738</ArticleId><ArticleId IdType="pubmed">11303967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>